Thomas E. Wood

Iconic Therapeutics, Inc. engages in the development of novel therapeutics for the treatment of serious eye disorders. Its product ICON-1, is a novel immune-conjugate fusion protein that works with the body’s immune system to address the root causes of inflammation and angiogenesis together, potentially altering the course of causes of blindness. The company was founded by Alan Garen, Kirk Dornbush, and Michael I. Sherman in 2003 and is headquartered in South San Francisco, CA.

Arvinas Operations, Inc. develops novel therapeutics for the treatment of cancer, pro-inflammatory, autoimmune and rare diseases. It offers proteolysis-targeting chimera PROTAC-based drugs that induce protein degradation to target and eliminate disease-causing proteins from the body. The company was founded by Craig M. Crews in July 2013 and is headquartered in New Haven, CT.

Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ.

Part of Jazz Pharmaceuticals Plc, Prostagen, Inc. develops treatments and diagnostics for prostate cancer. The company is based in Allendale, NJ. The company was founded by Mike I. Sherman. Prostagen was acquired by Jazz Pharmaceuticals (EUSA Pharma USA), Inc., part of Jazz Pharmaceuticals Plc from May 09, 2008 on June 16, 1999 for $2.60 million.

Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses

Oak Ridge National Laboratory provides technical and scientific research services. The firm performs basic and applied research in principal areas such as neutron science, energy, supercomputing, advanced materials and national security. It also has research programs in nuclear and atomic physics, nuclear fusion, and microscopy. The company was founded in 1943 and is headquartered in Oak Ridge, TN.

HistoRx, Inc. develops tissue-based diagnostic products. The company was founded on July 23, 2004 and is headquartered in Carlsbad, CA.

PhytoCeutica, Inc. develops drugs for the treatment of cancer. It focuses on preclinical studies, clinical investigations, and a platform technology to assess botanical quality control and reproducibility. The company was founded by Yale University, Patrick Kung and Dr. Yung-Chi Cheng in 1999 and is headquartered in New Haven. CT.

The Association of University Technology Managers engages in gathering and reporting detailed information about technology transfer. The firm also provides research reports, databases, learning center, and global technology portal and technology transfer practice manual. The company was founded by Larry Gilbert in 1974 and is headquartered in Oakbrook, IL.

Elm Street Advisors LLC (Elm Street Ventures) is a venture capital firm founded in 2006 by Robert A. Bettigole. The firm is headquartered in New Haven, Connecticut.

HighCape Partners Management LLC (HighCape Partners) is a private equity firm founded in 2013 by Kevin Rakin and Matt Zuga. The firm headquartered in Westport, Connecticut..

Artizan Biosciences, Inc. engages in the provision of healthcare services. It develops curative treatments for inflammatory diseases. The company was founded by Richard A. Flavell, Noah W. Palm and Marcel R. de Zoete and is headquartered in New Haven, CT.

HighCape Capital Acquisition Corp. II operates as a blank check company. Its objective is effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination. The company was founded on February 9, 2021 and is headquartered in New York, NY.